Sign In
5 Jun 2020 14:28
London, 5 June 2020
NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS
The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
a) | Name | Nikoloz Gamkrelidze | ||||||||
2. | Reason for the notification | |||||||||
a) | Position / status | PDMR, CEO | ||||||||
b) | Initial notification / amendment | Initial notification | ||||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | Georgia Healthcare Group PLC | ||||||||
b) | LEI: | 213800RJGJDDZENQER80 | ||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument
Identification Code
|
Nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
| ||||||||
b) | Nature of the transaction | Grant of nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2019 work year pursuant to the executive equity compensation plan.
Shares will vest on a straight-line basis in each of the second, third and fourth years following the work year, subject to the terms of his service agreement. | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information |
| ||||||||
| Aggregated volume
| Grant of 543,195 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2019 work year pursuant to the executive equity compensation plan.
| ||||||||
| Aggregated price | n/a | ||||||||
|
|
| ||||||||
e) | Dates of the transaction | 4 June 2020 | ||||||||
f)
| Place of the transaction | Outside of a trading venue | ||||||||
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
a) | Name | Irakli Gogia | ||||||||
2. | Reason for the notification | |||||||||
a) | Position / status | PDMR, Deputy CEO - Finance and Operations | ||||||||
b) | Initial notification / amendment | Initial notification | ||||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | Georgia Healthcare Group PLC | ||||||||
b) | LEI: | 213800RJGJDDZENQER80 | ||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument
Identification Code
|
Nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11 | ||||||||
b) | Nature of the transaction | Grant of nil-cost options over ordinary shares in respect of deferred salary shares for the 2019 work year pursuant to the executive equity compensation plan.
20% of the salary shares will vest in each of the second, third and fourth years following the work year, and the remaining 40% vest in the fifth year following the work year, subject to the terms of his service agreement | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information |
| ||||||||
| Aggregated volume
| Grant of 53,000 nil-cost options over ordinary shares in respect of deferred salary shares for the 2019 work year pursuant to the executive equity compensation plan. | ||||||||
| Aggregated price | n/a | ||||||||
|
|
| ||||||||
e) | Dates of the transaction | 4 June 2020 | ||||||||
f)
| Place of the transaction | Outside of a trading venue | ||||||||
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
a) | Name | Irakli Gogia | ||||||||
2. | Reason for the notification | |||||||||
a) | Position / status | PDMR, Deputy CEO - Finance and Operations | ||||||||
b) | Initial notification / amendment | Initial notification | ||||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | Georgia Healthcare Group PLC | ||||||||
b) | LEI: | 213800RJGJDDZENQER80 | ||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument
Identification Code
| Nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
| ||||||||
b) | Nature of the transaction | Grant of nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2019 work year pursuant to the executive equity compensation plan.
Shares will vest on a straight-line basis in each of the second, third and fourth years following the work year, subject to the terms of his service agreement. | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information |
| ||||||||
| Aggregated volume
| Grant of 150,466 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2019 work year pursuant to the executive equity compensation plan. | ||||||||
| Aggregated price | n/a | ||||||||
|
|
| ||||||||
e) | Dates of the transaction | 4 June 2020 | ||||||||
f)
| Place of the transaction | Outside of a trading venue | ||||||||
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
a) | Name | Giorgi Mindiashvili | ||||||||
2. | Reason for the notification | |||||||||
a) | Position / status | PDMR, Chief Operating Officer - Hospitals | ||||||||
b) | Initial notification / amendment | Initial notification | ||||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | Georgia Healthcare Group PLC | ||||||||
b) | LEI: | 213800RJGJDDZENQER80 | ||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument
Identification Code
|
Nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
| ||||||||
b) | Nature of the transaction | Grant of nil-cost options over ordinary shares in respect of deferred salary shares for the 2019 work year pursuant to the executive equity compensation plan.
20% of the salary shares will vest in each of the second, third and fourth years following the work year, and the remaining 40% vest in the fifth year following the work year, subject to the terms of his service agreement | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information |
| ||||||||
| Aggregated volume
| Grant of 53,000 nil-cost options over ordinary shares in respect of deferred salary shares for the 2019 work year pursuant to the executive equity compensation plan. | ||||||||
| Aggregated price | n/a | ||||||||
|
|
| ||||||||
e) | Dates of the transaction | 4 June 2020 | ||||||||
f)
| Place of the transaction | Outside of a trading venue | ||||||||
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
a) | Name | Giorgi Mindiashvili | ||||||||
2. | Reason for the notification | |||||||||
a) | Position / status | PDMR, Chief Operating Officer - Hospitals | ||||||||
b) | Initial notification / amendment | Initial notification | ||||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | Georgia Healthcare Group PLC | ||||||||
b) | LEI: | 213800RJGJDDZENQER80 | ||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument
Identification Code
|
Nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
| ||||||||
b) | Nature of the transaction | Grant of nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2019 work year pursuant to the executive equity compensation plan.
Shares will vest on a straight-line basis in each of the second, third and fourth years following the work year, subject to the terms of his service agreement. | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information |
| ||||||||
| Aggregated volume
| Grant of 105,326 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2019 work year pursuant to the executive equity compensation plan. | ||||||||
| Aggregated price | n/a | ||||||||
|
|
| ||||||||
e) | Dates of the transaction | 4 June 2020 | ||||||||
f)
| Place of the transaction | Outside of a trading venue | ||||||||
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
a) | Name | Enrico Beridze | ||||||||
2. | Reason for the notification | |||||||||
a) | Position / status | PDMR, Head of Business Development and Strategic Marketing | ||||||||
b) | Initial notification / amendment | Initial notification | ||||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | Georgia Healthcare Group PLC | ||||||||
b) | LEI: | 213800RJGJDDZENQER80 | ||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument
Identification Code
|
Nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
| ||||||||
b) | Nature of the transaction | Grant of nil-cost options over ordinary shares in respect of deferred salary shares for the 2019 work year pursuant to the executive equity compensation plan.
20% of the salary shares will vest in each of the second, third and fourth years following the work year, and the remaining 40% vest in the fifth year following the work year, subject to the terms of his service agreement | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information |
| ||||||||
| Aggregated volume
| Grant of 46,000 nil-cost options over ordinary shares in respect of deferred salary shares for the 2019 work year pursuant to the executive equity compensation plan.
| ||||||||
| Aggregated price | n/a | ||||||||
|
|
| ||||||||
e) | Dates of the transaction | 4 June 2020 | ||||||||
f)
| Place of the transaction | Outside of a trading venue | ||||||||
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
a) | Name | Enrico Beridze | ||||||||
2. | Reason for the notification | |||||||||
a) | Position / status | PDMR, Head of Business Development and Strategic Marketing | ||||||||
b) | Initial notification / amendment | Initial notification | ||||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | Georgia Healthcare Group PLC | ||||||||
b) | LEI: | 213800RJGJDDZENQER80 | ||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument
Identification Code
|
Nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
| ||||||||
b) | Nature of the transaction | Grant of nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2019 work year pursuant to the executive equity compensation plan.
Shares will vest on a straight-line basis in each of the second, third and fourth years following the work year, subject to the terms of his service agreement. | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information |
| ||||||||
| Aggregated volume
| Grant of 119,632 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2019 work year pursuant to the executive equity compensation plan. | ||||||||
| Aggregated price | n/a | ||||||||
|
|
| ||||||||
e) | Dates of the transaction | 4 June 2020 | ||||||||
f)
| Place of the transaction | Outside of a trading venue | ||||||||
|
|
|
|
|
Name of authorised official of issuer responsible for making notification:
Link Company Matters, Company Secretary
Follow the stocks
